Terms: = Lung cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
1948 results:
1. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
2. SH003 Enhances the Anti-cancer Effects of Dabrafenib on lung cancer Harboring
Choi YJ; Chung YH; Lee K; Jeong M; Ko SG
Anticancer Res; 2024 May; 44(5):1905-1913. PubMed ID: 38677764
[TBL] [Abstract] [Full Text] [Related]
3. Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.
Wang Y; Huang Z; Li B; Xue J; Guo C; Bing Z; Zheng Z; Song Y; Xu Y; Huang G; Li H; Yu X; Xia Y; Li R; Si X; Zhang L; Li J; Song L; Xiong Y; Gu D; Song M; Zhou Z; Chen R; Feng Z; Bie Z; Li X; Yang H; Li S; Liang N
Cancer Immunol Immunother; 2024 Apr; 73(6):111. PubMed ID: 38668781
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of
Watanabe H; Inoue Y; Karayama M; Yazawa S; Mochizuka Y; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Shinmura K; Inui N; Suda T
JCO Precis Oncol; 2024 Apr; 8():e2300538. PubMed ID: 38662982
[TBL] [Abstract] [Full Text] [Related]
5. Temporal trends and regional variability in braf and KRAS genetic testing in Denmark (2010-2022): Implications for precision medicine.
Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
[TBL] [Abstract] [Full Text] [Related]
6. Targeted therapeutic options in early and metastatic NSCLC-overview.
Gálffy G; Morócz É; Korompay R; Hécz R; Bujdosó R; Puskás R; Lovas T; Gáspár E; Yahya K; Király P; Lohinai Z
Pathol Oncol Res; 2024; 30():1611715. PubMed ID: 38605928
[TBL] [Abstract] [Full Text] [Related]
7. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
8. braf/MEK-targeted therapy in braf ex15 p.T599dup mutation-driven NSCLC: a case report.
Jiang L; Yang P; Liu Y; Li J
J Cancer Res Clin Oncol; 2024 Mar; 150(3):162. PubMed ID: 38538919
[TBL] [Abstract] [Full Text] [Related]
9. If it's a target, it's a pan-cancer target: Tissue is not the issue.
Adashek JJ; Kato S; Sicklick JK; Lippman SM; Kurzrock R
Cancer Treat Rev; 2024 Apr; 125():102721. PubMed ID: 38522181
[TBL] [Abstract] [Full Text] [Related]
10. Detection of Single Nucleotide Polymorphisms of Circulating Tumor DNA by Strand Displacement Amplification Coupled with Liquid Chromatography.
Ma Z; Xu J; Hou W; Lei Z; Li T; Shen W; Yu H; Liu C; Zhang J; Tang S
Anal Chem; 2024 Apr; 96(13):5195-5204. PubMed ID: 38520334
[TBL] [Abstract] [Full Text] [Related]
11. Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell lung cancer in Administrative Claims Databases.
Patel SP; Wang R; Zhou SQ; Sheinson D; Johnson A; Lee JS
JCO Clin Cancer Inform; 2024 Mar; 8():e2300165. PubMed ID: 38502111
[TBL] [Abstract] [Full Text] [Related]
12. The outcome in patients with braf-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.
Kopecký J; Pásek M; Lakomý R; Melichar B; Mrazová I; Kubeček O; Arenbergerová M; Lemstrová R; Švancarová A; Tretera V; Hlodáková A; Žváčková K
Cancer Med; 2024 Mar; 13(5):e6982. PubMed ID: 38491825
[TBL] [Abstract] [Full Text] [Related]
13. Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating braf Mutation: A First in Non-Small Cell lung cancer.
Sharp JA; Jones D; Rotow JK; Fidias PM; Bertino E; Owen DH
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38479107
[TBL] [Abstract] [Full Text] [Related]
14. Variant Analysis of miRNA Regulatory Genes in 35 Sporadic lung Carcinoma Tumors.
Bağcı Ö; Özdemir EM; Şanlıtürk B
Dokl Biochem Biophys; 2023 Dec; 513(Suppl 1):S1-S7. PubMed ID: 38472669
[TBL] [Abstract] [Full Text] [Related]
15. Association of PD-L1 expression with driver gene mutations and clinicopathological characteristics in non-small cell lung cancer: A real-world study of 10 441 patients.
Ruiz G; Enrico D; Mahmoud YD; Ruiz A; Cantarella MF; Leguina L; Barberis M; Beña A; Brest E; Starapoli S; Mendoza Bertelli A; Tsou F; Pupareli C; Coppola MP; Scocimarro A; Sena S; Levit P; Perfetti A; Aman E; Girotti MR; Arrieta O; Martín C; Salanova R
Thorac Cancer; 2024 Apr; 15(11):895-905. PubMed ID: 38456253
[TBL] [Abstract] [Full Text] [Related]
16. [Intraductal carcinomas of the salivary glands: a clinicopathological and molecular genetic analysis of twenty-seven cases].
Sun Q; Sun JJ; Wang M; Zhang L; Zhang XW; Wei JG; Kong LF; Li J
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):250-256. PubMed ID: 38433052
[No Abstract] [Full Text] [Related]
17. Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the braf V600E mutation with high expression of PD-L1: A case report.
Inoue T; Kunimasa K; Tamiya M; Kawamura T; Minami T; Nishino K
Thorac Cancer; 2024 Apr; 15(11):929-933. PubMed ID: 38429896
[TBL] [Abstract] [Full Text] [Related]
18. Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
Ohtaki Y; Nagashima T; Okano N; Kubo N; Ohtaka T; Sunaga N; Sakurai R; Miura Y; Nakazawa S; Kawatani N; Yazawa T; Yoshikawa R; Narusawa E; Shirabe K
Thorac Cancer; 2024 Apr; 15(11):859-866. PubMed ID: 38414316
[TBL] [Abstract] [Full Text] [Related]
19. Primary endobronchial melanoma: a case report and clinical management indications.
Barisione E; Boutros A; Mora M; Spagnolo F; Tanda ET; Genova C; Tagliabue E
BMC Pulm Med; 2024 Feb; 24(1):97. PubMed ID: 38402179
[TBL] [Abstract] [Full Text] [Related]
20. A Challenging Correlation between Tumor Cellularity and Somatic Variant Allele Fraction in lung and Colorectal cancers-Specimens of Low Tumor Percentage Should Be Analyzed with Caution.
Zarabi SK; Zhai L; Cheng YW
Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397405
[No Abstract] [Full Text] [Related]
[Next]